Our findings underscore the critical role of the LncRNA H19/hsa-miR-138-5p/hsa-miR-22-3p/BMP2 pathway in TMZ resistance acquisition in GBM cells, suggesting targeting this pathway as a promising strategy to address TMZ resistance in GBM. This evidence concerns the gene BMP2 and glioblastoma.